Apollomics Inc(APLM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APLM Apollomics Inc

元旦休市 12-31 16:00:00 EST

18.70

-1.98

-9.60%

盘后18.70

+0.000.00%

19:22 EST

最高22.08	最低18.70	成交量4.18万
今开21.01	昨收20.68	日振幅16.37%
总市值4,007万	流通市值3,392万	总股本214.33万
成交额87.48万	换手率2.30%	流通股本181.46万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"APLM","market":"US","secType":"STK","nameCN":"Apollomics Inc","latestPrice":18.695,"timestamp":1767214800000,"preClose":20.68,"halted":0,"volume":41765,"hourTrading":{"tag":"盘后","latestPrice":18.695,"preClose":18.695,"latestTime":"19:22 EST","volume":17,"amount":340.6,"timestamp":1767226965090},"delay":0,"floatShares":1814600,"shares":2143300,"eps":-52.80196,"marketStatus":"元旦休市","change":-1.985,"latestTime":"12-31 16:00:00 EST","open":21.01,"high":22.0808,"low":18.695,"amount":874802.8823050001,"amplitude":0.163723,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-52.80196,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1767344400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":20.68,"preHourTrading":{"tag":"盘前","latestPrice":21.4,"preClose":22.29,"latestTime":"08:53 EST","volume":1,"amount":21.4,"timestamp":1767189214076},"postHourTrading":{"tag":"盘后","latestPrice":18.695,"preClose":18.695,"latestTime":"19:22 EST","volume":17,"amount":340.6,"timestamp":1767226965090},"volumeRatio":1.316668875952867},"requestUrl":"/m/hq/s/APLM","defaultTab":"news","newsList":[{"id":"1103199123","title":"Apollomics：公司预计终止不会对其整体财务状况或经营成果产生重大不利影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1103199123","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103199123?lang=zh_cn&edition=full","pubTime":"2025-12-13 00:41","pubTimestamp":1765557670,"startTime":"0","endTime":"0","summary":"Apollomics：公司预计终止不会对其整体财务状况或经营成果产生重大不利影响","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"1120613943","title":"Apollomics：因爱迪生未能履行某些重要的业绩与报告义务而终止协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1120613943","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120613943?lang=zh_cn&edition=full","pubTime":"2025-12-13 00:39","pubTimestamp":1765557566,"startTime":"0","endTime":"0","summary":"Apollomics：因爱迪生未能履行某些重要的业绩与报告义务而终止协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"1199157602","title":"Apollomics于12月11日向Edison Oncology正式发布终止通知，涉及Apl-122的开发与商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1199157602","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199157602?lang=zh_cn&edition=full","pubTime":"2025-12-13 00:38","pubTimestamp":1765557516,"startTime":"0","endTime":"0","summary":"Apollomics于12月11日向Edison Oncology正式发布终止通知，涉及Apl-122的开发与商业化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"2587368751","title":"冠科美博盘中异动 股价大涨17.85%报17.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2587368751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587368751?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:43","pubTimestamp":1764341031,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日22时43分，冠科美博股票出现异动，股价快速上涨17.85%。截至发稿，该股报17.96美元/股，成交量566股，换手率0.03%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。冠科美博股票所在的生物技术行业中，整体跌幅为0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128224352978501ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128224352978501ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":1},{"id":"1199023344","title":"Apollomics达成与两名少数投资者相关法律诉讼的和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1199023344","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199023344?lang=zh_cn&edition=full","pubTime":"2025-11-20 05:08","pubTimestamp":1763586499,"startTime":"0","endTime":"0","summary":"Apollomics达成与两名少数投资者相关法律诉讼的和解协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2582878543","title":"冠科美博盘中异动 快速拉升7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582878543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582878543?lang=zh_cn&edition=full","pubTime":"2025-11-11 02:11","pubTimestamp":1762798291,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日02时11分，冠科美博股票出现波动，股价急速上涨7.19%。截至发稿，该股报15.20美元/股，成交量7501股，换手率0.35%，振幅9.20%。冠科美博股票所在的生物技术行业中，整体涨幅为0.51%。冠科美博公司简介：冠科美博有限公司是一家临床阶段的创新型生物制药公司，致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法，利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111102113194fbdf5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111102113194fbdf5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLTO","APLM","BK4139"],"gpt_icon":0},{"id":"2580428494","title":"冠科美博盘中异动 早盘股价大涨20.33%报13.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580428494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580428494?lang=zh_cn&edition=full","pubTime":"2025-10-31 22:07","pubTimestamp":1761919622,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日22时07分，冠科美博股票出现异动，股价快速拉升20.33%。截至发稿，该股报13.97美元/股，成交量1254股，换手率0.06%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-53.86百万美元，每股收益-52.80美元，毛利-361000.00美元，市盈率-0.26倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。冠科美博股票所在的生物技术行业中，整体跌幅为0.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031220702a4802f20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031220702a4802f20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2579312199","title":"冠科美博盘中异动 早盘快速下跌11.13%报12.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579312199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579312199?lang=zh_cn&edition=full","pubTime":"2025-10-30 21:32","pubTimestamp":1761831125,"startTime":"0","endTime":"0","summary":"北京时间2025年10月30日21时32分，冠科美博股票出现波动，股价快速跳水11.13%。截至发稿，该股报12.54美元/股，成交量3693股，换手率0.17%，振幅12.69%。冠科美博股票所在的生物技术行业中，整体跌幅为1.28%。冠科美博公司简介：冠科美博有限公司是一家临床阶段的创新型生物制药公司，致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法，利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030213205a47dfc9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030213205a47dfc9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"2578575542","title":"冠科美博盘中异动 急速跳水11.28%报25.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578575542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578575542?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:31","pubTimestamp":1761312677,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时31分，冠科美博股票出现异动，股价大幅下挫11.28%。截至发稿，该股报25.03美元/股，成交量1220股，换手率0.06%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-53.86百万美元，每股收益-52.80美元，毛利-361000.00美元，市盈率-0.51倍。冠科美博股票所在的生物技术行业中，整体涨幅为0.40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213118a6cc2f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213118a6cc2f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2576900084","title":"冠科美博盘中异动 股价大涨5.38%报20.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576900084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576900084?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:31","pubTimestamp":1760621517,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日21时31分，冠科美博股票出现波动，股价快速上涨5.38%。截至发稿，该股报20.55美元/股，成交量1.6554万股，换手率0.77%，振幅1.90%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-53.86百万美元，每股收益-52.80美元，毛利-361000.00美元，市盈率-0.39倍。冠科美博股票所在的生物技术行业中，整体涨幅为0.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213157a6bd1f7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213157a6bd1f7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"1169891245","title":"Apollomics - 纳斯达克取消该公司的上诉听证会；证券继续上市并在纳斯达克交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1169891245","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169891245?lang=zh_cn&edition=full","pubTime":"2025-10-16 02:38","pubTimestamp":1760553490,"startTime":"0","endTime":"0","summary":"Apollomics - 纳斯达克取消该公司的上诉听证会；证券继续上市并在纳斯达克交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"1199180126","title":"Apollomics Inc预期将尽快终止Sparta临床试验的所有相关活动","url":"https://stock-news.laohu8.com/highlight/detail?id=1199180126","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199180126?lang=zh_cn&edition=full","pubTime":"2025-08-28 18:32","pubTimestamp":1756377138,"startTime":"0","endTime":"0","summary":"Apollomics Inc表示，预期将尽快停止与Sparta临床试验相关的所有活动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2558661523","title":"冠科美博盘中异动 临近午盘股价大涨7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558661523?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:32","pubTimestamp":1754926321,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时32分，冠科美博股票出现异动，股价大幅拉升7.03%。截至发稿，该股报6.07美元/股，成交量4.0829万股，换手率3.70%，振幅0.00%。冠科美博股票所在的生物技术行业中，整体涨幅为0.25%。冠科美博公司简介：冠科美博有限公司是一家临床阶段的创新型生物制药公司，致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法，利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811233201a4824145&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811233201a4824145&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2557433933","title":"冠科美博盘中异动 大幅跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557433933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557433933?lang=zh_cn&edition=full","pubTime":"2025-08-05 03:49","pubTimestamp":1754336979,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时49分，冠科美博股票出现异动，股价大幅下跌5.37%。截至发稿，该股报5.56美元/股，成交量4969股，换手率0.45%，振幅4.80%。冠科美博股票所在的生物技术行业中，整体涨幅为1.68%。冠科美博公司简介：冠科美博有限公司是一家临床阶段的创新型生物制药公司，致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法，利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805034939a6d2e798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805034939a6d2e798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2555029887","title":"冠科美博盘中异动 快速跳水6.35%报5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555029887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555029887?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:24","pubTimestamp":1753899885,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时24分，冠科美博股票出现波动，股价急速下挫6.35%。截至发稿，该股报5.75美元/股，成交量1.3951万股，换手率1.26%，振幅7.87%。冠科美博股票所在的生物技术行业中，整体涨幅为0.77%。冠科美博公司简介：冠科美博有限公司是一家临床阶段的创新型生物制药公司，致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法，利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310224459728537d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310224459728537d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2555068345","title":"冠科美博盘中异动 临近午盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555068345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555068345?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:51","pubTimestamp":1753804292,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时51分，冠科美博股票出现波动，股价快速下跌5.02%。截至发稿，该股报6.05美元/股，成交量6336股，换手率0.57%，振幅9.58%。冠科美博股票所在的生物技术行业中，整体涨幅为0.29%。冠科美博公司简介：冠科美博有限公司是一家临床阶段的创新型生物制药公司，致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法，利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729235133a6c820f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729235133a6c820f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2552431165","title":"冠科美博盘中异动 临近收盘快速上涨7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552431165?lang=zh_cn&edition=full","pubTime":"2025-07-18 04:15","pubTimestamp":1752783354,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日04时15分，冠科美博股票出现异动，股价快速拉升7.32%。截至发稿，该股报6.45美元/股，成交量6037股，换手率0.55%，振幅6.16%。冠科美博股票所在的生物技术行业中，整体涨幅为0.29%。冠科美博公司简介：冠科美博有限公司是一家临床阶段的创新型生物制药公司，致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法，利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718041554a6b06cb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718041554a6b06cb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"2551182723","title":"冠科美博盘中异动 早盘股价大涨7.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551182723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551182723?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:47","pubTimestamp":1752504450,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时47分，冠科美博股票出现波动，股价快速上涨7.52%。截至发稿，该股报5.86美元/股，成交量3497股，换手率0.32%，振幅3.12%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。冠科美博股票所在的生物技术行业中，整体涨幅为1.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714224730a44a3d02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714224730a44a3d02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2550546339","title":"冠科美博盘中异动 股价大跌6.97%报5.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550546339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550546339?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:24","pubTimestamp":1752243880,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时24分，冠科美博股票出现波动，股价急速跳水6.97%。截至发稿，该股报5.30美元/股，成交量4346股，换手率0.39%，振幅9.04%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。冠科美博股票所在的生物技术行业中，整体跌幅为0.69%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711222441a6a41033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711222441a6a41033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"2550265338","title":"冠科美博盘中异动 急速下挫7.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550265338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550265338?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:33","pubTimestamp":1752067996,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时33分，冠科美博股票出现波动，股价大幅跳水7.20%。截至发稿，该股报6.07美元/股，成交量31.6313万股，换手率28.67%，振幅4.13%。冠科美博股票所在的生物技术行业中，整体涨幅为1.12%。冠科美博公司简介：冠科美博有限公司是一家临床阶段的创新型生物制药公司，致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法，利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213317979fb5dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213317979fb5dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.apollomicsinc.com","stockEarnings":[{"period":"1week","weight":0.0392},{"period":"1month","weight":0.3344},{"period":"3month","weight":0.0142},{"period":"6month","weight":2.0448},{"period":"1year","weight":0.9174},{"period":"ytd","weight":0.9174}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.019},{"period":"6month","weight":0.0905},{"period":"1year","weight":0.1635},{"period":"ytd","weight":0.1635}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"冠科美博有限公司于2015年5月21日在开曼群岛注册成立。他们是一家创新的临床阶段生物技术公司，专注于发现和开发肿瘤疗法，以满足未满足的医疗需求。自2015年成立以来，他们已经在11个专注于肿瘤学的项目中建立了一个包含9种候选药物的管道，其中6种候选药物处于临床阶段。","exchange":"NASDAQ","name":"Apollomics Inc","nameEN":"Apollomics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apollomics Inc(APLM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apollomics Inc(APLM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apollomics Inc,APLM,Apollomics Inc股票,Apollomics Inc股票老虎,Apollomics Inc股票老虎国际,Apollomics Inc行情,Apollomics Inc股票行情,Apollomics Inc股价,Apollomics Inc股市,Apollomics Inc股票价格,Apollomics Inc股票交易,Apollomics Inc股票购买,Apollomics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apollomics Inc(APLM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apollomics Inc(APLM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}